306 related articles for article (PubMed ID: 33278936)
21. Predictors of caregiver adherence to administration of amodiaquine during delivery of seasonal malaria chemoprevention in Nigeria, Burkina Faso, Chad, and Togo.
Ibinaiye T; Oresanya O; Oguoma C; Aidenagbon A; Ogunmola O; Rassi C; Richardson S
Malar J; 2023 May; 22(1):148. PubMed ID: 37147685
[TBL] [Abstract][Full Text] [Related]
22. Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention.
Chandramohan D; Dicko A; Zongo I; Sagara I; Cairns M; Kuepfer I; Diarra M; Barry A; Tapily A; Nikiema F; Yerbanga S; Coumare S; Thera I; Traore A; Milligan P; Tinto H; Doumbo O; Ouedraogo JB; Greenwood B
N Engl J Med; 2019 Jun; 380(23):2197-2206. PubMed ID: 30699301
[TBL] [Abstract][Full Text] [Related]
23. Modeled Impact of Seasonal Malaria Chemoprevention on District-Level Suspected and Confirmed Malaria Cases in Chad Based on Routine Clinical Data (2013-2018).
Richardson S; Moukenet A; Diar MSI; de Cola MA; Rassi C; Counihan H; Roca-Feltrer A
Am J Trop Med Hyg; 2021 Oct; 105(6):1712-1721. PubMed ID: 34662864
[TBL] [Abstract][Full Text] [Related]
24. Seasonal malaria chemoprevention combined with community case management of malaria in children under 10 years of age, over 5 months, in south-east Senegal: A cluster-randomised trial.
Ndiaye JLA; Ndiaye Y; Ba MS; Faye B; Ndiaye M; Seck A; Tine R; Thior PM; Atwal S; Beshir K; Sutherland C; Gaye O; Milligan P
PLoS Med; 2019 Mar; 16(3):e1002762. PubMed ID: 30865632
[TBL] [Abstract][Full Text] [Related]
25. Investigating selected host and parasite factors potentially impacting upon seasonal malaria chemoprevention in Bama, Burkina Faso.
Somé FA; Bazié T; Ehrlich HY; Goodwin J; Lehane A; Neya C; Zachari K; Wade M; Ouattara JM; Foy BD; Dabiré RK; Parikh S; Ouédraogo JB
Malar J; 2020 Jul; 19(1):238. PubMed ID: 32631416
[TBL] [Abstract][Full Text] [Related]
26. Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children.
Conteh L; Patouillard E; Kweku M; Legood R; Greenwood B; Chandramohan D
PLoS One; 2010 Aug; 5(8):e12223. PubMed ID: 20808923
[TBL] [Abstract][Full Text] [Related]
27. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
[TBL] [Abstract][Full Text] [Related]
28. Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali.
Diawara F; Steinhardt LC; Mahamar A; Traore T; Kone DT; Diawara H; Kamate B; Kone D; Diallo M; Sadou A; Mihigo J; Sagara I; Djimde AA; Eckert E; Dicko A
Malar J; 2017 Aug; 16(1):325. PubMed ID: 28797263
[TBL] [Abstract][Full Text] [Related]
29. A non-randomized controlled trial to assess the protective effect of SMC in the context of high parasite resistance in Uganda.
Nuwa A; Baker K; Bonnington C; Odongo M; Kyagulanyi T; Bwanika JB; Richardson S; Nabakooza J; Achan J; Kajubi R; Odong DS; Nakirunda M; Magumba G; Beinomugisha G; Marasciulo-Rice M; Abio H; Rassi C; Rutazaana D; Rubahika D; Tibenderana J; Opigo J
Malar J; 2023 Feb; 22(1):63. PubMed ID: 36814301
[TBL] [Abstract][Full Text] [Related]
30. Seasonal malaria chemoprevention: successes and missed opportunities.
Coldiron ME; Von Seidlein L; Grais RF
Malar J; 2017 Nov; 16(1):481. PubMed ID: 29183327
[TBL] [Abstract][Full Text] [Related]
31. A trial of the efficacy, safety and impact on drug resistance of four drug regimens for seasonal intermittent preventive treatment for malaria in Senegalese children.
Sokhna C; Cissé B; Bâ el H; Milligan P; Hallett R; Sutherland C; Gaye O; Boulanger D; Simondon K; Simondon F; Targett G; Lines J; Greenwood B; Trape JF
PLoS One; 2008 Jan; 3(1):e1471. PubMed ID: 18213379
[TBL] [Abstract][Full Text] [Related]
32. Selection of drug resistance-mediating Plasmodium falciparum genetic polymorphisms by seasonal malaria chemoprevention in Burkina Faso.
Somé AF; Zongo I; Compaoré YD; Sakandé S; Nosten F; Ouédraogo JB; Rosenthal PJ
Antimicrob Agents Chemother; 2014 Jul; 58(7):3660-5. PubMed ID: 24733476
[TBL] [Abstract][Full Text] [Related]
33. Impact of seasonal malaria chemoprevention based on the number of medicines doses received on malaria burden among children aged 3-59 months in Nigeria: A propensity score-matched analysis.
Huang S; Baker K; Ibinaiye T; Oresanya O; Nnaji C; Richardson S
Trop Med Int Health; 2024 Jun; ():. PubMed ID: 38842452
[TBL] [Abstract][Full Text] [Related]
34. Two strategies for the delivery of IPTc in an area of seasonal malaria transmission in the Gambia: a randomised controlled trial.
Bojang KA; Akor F; Conteh L; Webb E; Bittaye O; Conway DJ; Jasseh M; Wiseman V; Milligan PJ; Greenwood B
PLoS Med; 2011 Feb; 8(2):e1000409. PubMed ID: 21304921
[TBL] [Abstract][Full Text] [Related]
35. Understanding and maximising the community impact of seasonal malaria chemoprevention in Burkina Faso (INDIE-SMC): study protocol for a cluster randomised evaluation trial.
Moreno M; Barry A; Gmeiner M; Yaro JB; Sermé SS; Byrne I; Ramjith J; Ouedraogo A; Soulama I; Grignard L; Soremekun S; Koele S; Ter Heine R; Ouedraogo AZ; Sawadogo J; Sanogo E; Ouedraogo IN; Hien D; Sirima SB; Bradley J; Bousema T; Drakeley C; Tiono AB
BMJ Open; 2024 Mar; 14(3):e081682. PubMed ID: 38479748
[TBL] [Abstract][Full Text] [Related]
36. Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial.
Tagbor H; Antwi GD; Acheampong PR; Bart Plange C; Chandramohan D; Cairns M
Trop Med Int Health; 2016 Feb; 21(2):224-35. PubMed ID: 26578353
[TBL] [Abstract][Full Text] [Related]
37. [Not Available].
Ouoba J; Lankoandé-Haro S; Fofana S; Nacoulma AP; Kaboré L; Sombié I; Rouamba T; Kirakoya-Samadoulougou F
Sante Publique; 2023; 35(5):121-132. PubMed ID: 38423956
[TBL] [Abstract][Full Text] [Related]
38. Plasmodium falciparum drug resistance-associated mutations in isolates from children living in endemic areas of Burkina Faso.
Tarama CW; Soré H; Siribié M; Débé S; Kinda R; Ganou A; Nonkani WG; Tiendrebeogo F; Bantango W; Yira K; Sagnon A; Ilboudo S; Hien EY; Guelbéogo MW; Sagnon N; Traoré Y; Ménard D; Gansané A
Malar J; 2023 Jul; 22(1):213. PubMed ID: 37474966
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic considerations in seasonal malaria chemoprevention.
Chotsiri P; White NJ; Tarning J
Trends Parasitol; 2022 Aug; 38(8):673-682. PubMed ID: 35688778
[TBL] [Abstract][Full Text] [Related]
40. Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention.
Chandramohan D; Zongo I; Sagara I; Cairns M; Yerbanga RS; Diarra M; Nikièma F; Tapily A; Sompougdou F; Issiaka D; Zoungrana C; Sanogo K; Haro A; Kaya M; Sienou AA; Traore S; Mahamar A; Thera I; Diarra K; Dolo A; Kuepfer I; Snell P; Milligan P; Ockenhouse C; Ofori-Anyinam O; Tinto H; Djimde A; Ouédraogo JB; Dicko A; Greenwood B
N Engl J Med; 2021 Sep; 385(11):1005-1017. PubMed ID: 34432975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
